Cellectis (CLLS) Total Liabilities (2013 - 2026)

Cellectis' Total Liabilities history runs 14 years deep, the most recent figure standing at $229.3 million for Q1 2026.

• On a quarterly basis, Total Liabilities fell 7.51% year-over-year to $229.3 million in Q1 2026; TTM through Mar 2026 was $229.3 million, a 7.51% decrease from a year earlier, with the FY2025 full-year figure at $248.8 million, down 1.46% from the prior year.
• Total Liabilities retreated to $229.3 million in Q1 2026 per CLLS's latest filing, from $248.8 million in the prior quarter.
• Across five years, Total Liabilities topped out at $320.9 million in Q2 2022 and bottomed at $15.2 million in Q4 2022.
• The 5-year median for Total Liabilities is $249.6 million (2023), against an average of $226.1 million.
• Across the five-year window, Total Liabilities sank 94.71% in 2022 and soared 1543.24% in 2023, its largest moves.
• Year by year, Total Liabilities stood at $15.2 million in 2022, then jumped by 1543.24% to $249.6 million in 2023, then climbed by 1.18% to $252.5 million in 2024, then declined by 1.46% to $248.8 million in 2025, then slipped by 7.86% to $229.3 million in 2026.
• Per Business Quant, the three latest CLLS Total Liabilities figures stand at $229.3 million (Q1 2026), $248.8 million (Q4 2025), and $242.6 million (Q3 2025).